Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04496843

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
220 (estimated)
Sponsor
Withings · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers

Summary

Sleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed and therefore not treated. It is however impracticable to propose a diagnostic test of polygraphy (PG) or polysomnography (PSG) to every patient because of the cost and insufficient availability of these exams. It would therefore be useful to carry out a screening test before directing the patient to a complete test. Several simplified polygraph systems with 2 or 3 channels have been proposed (nasal cannula, oximetry, heart rate) but they generally record only one night and remain intrusive enough to perturb the sleep. The Withings HWA09 is a wrist-worn watch, which allows screening of SAS from four signals: movement, heart rate, breathing rate and blood oxygen saturation (SpO2). The objective of the present study is to validate the diagnostic performance of the Withings HWA09 for the detection of SAS compared to PSG.

Detailed description

Subjects are patients having a prescription for a one-night polysomnographic consultation in order to diagnose potential sleep disorders. The investigator will collect the consent before including any patient in this study. The study last one night per patient, during which saturation signal recordings and the sleep apnea detection will be made by the HWA09 watch, in comparison to the polysomnography.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHWA09 MeasurementSimultaneous recording of Withings HWA09 Device and PSG devices for the reference.

Timeline

Start date
2020-01-16
Primary completion
2021-01-31
Completion
2026-12-31
First posted
2020-08-03
Last updated
2026-02-18

Locations

2 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT04496843. Inclusion in this directory is not an endorsement.